Filter by

Latest From This Topic

New Delhi, August 28   
CCI direction: Sun, Ranbaxy to publish details of merger

Sun Pharma and Ranbaxy, which had entered into a $4-billion deal in April, have told the Bombay Stock Exchange that they will publish the details of the “proposed combination” within 10 wor... »

New Delhi, Aug 28  
Sun-Ranbaxy deal: Competition panel expands probe; seeks public scrutiny
Widening its scrutiny of the multi-billion dollar Sun Pharma-Ranbaxy deal, fair trade watchdog CCI has asked the two pharma majors to make public specific details of their proposed merger within t... »
Thursday, August 28, 2014
Communication received from the Competition Commission of India in respect of the proposed combination between the Company and Sun Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd has informed BSE that the Company has received direction vide letter dated August 27, 2014 under Section 29(2) of the Competition Act, 2002 from the Competition Commission... »

More Articles about:  Ranbaxy Laboratories Limited


More Articles about:  Ranbaxy Laboratories Limited

Browse topics

Track your company
Today's Poll
Will the lifting of the monthly cap on subsidised cylinders help the common man?
Can't say

Follow us on...

How will the new ASCI guidelines influence fairness advertising? »

Tweets @businessline


Exchange Rate

Dollar Spot Forward Rate

Open-Ended Mutual Funds

MCX-SX Currency Futures

NSE Currency Futures

Comments to: Copyright © 2014, The Hindu Business Line.